Structure Therapeutics, Inc. (GPCR)
41.27
-0.26
(-0.63%)
USD |
NASDAQ |
Jun 11, 10:05
Structure Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 81.93% |
| Novo Nordisk A/S | 85.96% |
| Viking Therapeutics, Inc. | -- |
| Pfizer Inc. | 66.67% |
| Tarsus Pharmaceuticals, Inc. | 94.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.01% |
| Return on Assets | -15.22% |
| Return on Invested Capital | -15.91% |
| Return on Net Operating Assets | -1.47K% |